SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
STAAR Surgical published a press release on August 12, 2026 reporting second quarter 2026 financial results for the quarter ended July 3, 2026, disclosing net sales of $93.5 million (up 111% year-over-year), net income of $8.1 million ($0.16 per diluted share), and adjusted EBITDA of $20.0 million, with material improvements in revenue, profitability, and gross margin.
View raw filing on EDGAR →This is a Q2 2026 news release disclosing Pan American Silver's second quarter financial results, including revenue of $1.1 billion, net earnings of $305 million ($0.72 basic EPS), and attributable free cash flow of $344 million. The release reports production metrics (6.5 million ounces of silver, 166 thousand ounces of gold), operational updates, and revised 2026 guidance. As a quarterly earnings announcement with comprehensive financial and operational results, this is a classic earnings_release event that would materially affect a reasonable investor's assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →Jack in the Box issued a press release on August 12, 2026 announcing third quarter fiscal 2026 financial results, including same-store sales decline of 1.1%, diluted EPS from continuing operations of $1.08, and operating EPS of $0.96. The disclosure is a standard quarterly earnings announcement with detailed financial statements, operational metrics, and forward guidance, clearly fitting the earnings_release category under Item 2.02.
View raw filing on EDGAR →Santander Holdings USA disclosed Q2 2026 financial results showing net income of $585M (up 17.5% YoY) and net interest income of $1.5B (up 2.7% YoY), with key metrics including a CET1 ratio of 13.7% and deposit levels of $79.6B. The disclosure was made through a comprehensive fixed income investor presentation dated August 12, 2026, covering revenue, expenses, credit performance, and balance sheet trends.
View raw filing on EDGAR →Pulte Mortgage, a wholly-owned subsidiary of PulteGroup, entered into a Master Repurchase Agreement with Truist Bank providing a $625 million maximum aggregate commitment to finance mortgage loan originations. This creates a new direct financial obligation and credit facility for the registrant's financing operations.
View raw filing on EDGAR →Clean Harbors announced entry into a definitive agreement to acquire EnviroServe for $470 million in cash, expected to close in the second half of 2026. This is a material acquisition disclosed under Item 8.01 (Other Events) via press release. The transaction involves a substantial purchase price, strategic expansion of the company's environmental services segment, and anticipated $25 million in cost synergies, making it clearly material to investors.
View raw filing on EDGAR →The Board declared quarterly dividends on three classes of common stock ($1.60 per share) and six classes of preferred stock (ranging from $0.3046875 to $0.4296875 per share), payable in September and October 2026. This is a routine but material dividend declaration that affects all equity holders and is standard disclosure under Item 8.01 for dividend announcements.
View raw filing on EDGAR →This Item 2.02 disclosure reports Cisco's quarterly and fiscal year 2026 financial results, with a press release attached as Exhibit 99.1. The filing explicitly states "Cisco Systems, Inc. ("Cisco") reported its results of operations for its fiscal fourth quarter and fiscal year 2026 ended July 25, 2026." The press release contains comprehensive earnings data including revenue of $63.3 billion (up 12% YoY), net income of $13.3 billion (up 30% YoY), and EPS of $3.33 (up 31% YoY), along with forward guidance for Q1 and FY 2027. This is a standard earnings release disclosure material to investors.
View raw filing on EDGAR →Trimble reported Q2 2026 financial results (quarter ended July 3, 2026) with revenue of $972.0 million (up 11% YoY), a GAAP net loss of $(471.7) million driven by a $562.0 million goodwill impairment, and non-GAAP net income of $200.3 million. The company raised full-year 2026 guidance and announced a new $1.0 billion share repurchase authorization.
View raw filing on EDGAR →The Board authorized a new $1.0 billion share repurchase program, replacing a prior authorization with $608.2 million remaining, representing a significant capital allocation decision.
View raw filing on EDGAR →Fossil Group issued a press release on August 12, 2026 announcing financial results for the fiscal quarter ended July 4, 2026, disclosing net sales of $209.7 million, gross margin expansion to 62.4%, operating results, and raising full-year 2026 financial guidance. This is a standard quarterly earnings release with detailed financial statements and forward guidance, clearly falling under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →This is a quarterly earnings release for Suzano S.A. announcing consolidated results for 2Q26, including Adjusted EBITDA of R$4.7 billion, free cash flow of R$3.3 billion, and detailed operational and financial metrics. The document explicitly states "announces today its consolidated results for the second quarter of 2026 (2Q26)" and is titled "EARNINGS RELEASE 2Q26," making it a clear disclosure of quarterly financial results material to investors.
View raw filing on EDGAR →The exhibit is a letter from Joint Provisional Liquidators of Global Cord Blood Corporation dated 6 August 2026, disclosing the company's status in provisional liquidation under a Cayman Islands court order from September 2022. The letter details the JPLs' ongoing fee approval applications and the company's inability to hold shareholder meetings due to a dispute over the register of members. This is a terminal event—the company is in liquidation proceedings—that does not fit a specific terminal category (not bankruptcy_filing per se, but a court-ordered liquidation), making terminal_other the appropriate classification.
View raw filing on EDGAR →Sysco disclosed a presentation to investors regarding its previously announced agreement to acquire JRD Unico, Inc. and Warehouse Realty, LLC (Jetro Restaurant Depot), detailing the strategic rationale, financial projections, synergy expectations, pro forma revenue and EBITDA impacts, expected EPS accretion, and integration plans.
View raw filing on EDGAR →The disclosure announces receipt of requisite consents from holders of six series of outstanding debt notes (totaling approximately $1.03 billion in aggregate principal) to amend the indentures governing those notes. While this is technically an amendment to existing debt rather than issuance of new debt, it materially modifies the terms and covenants of direct financial obligations and involves execution of supplemental indentures. The amendment aligns covenants with Anglo American's debt structure in connection with the pending merger, and contemplates a potential guarantee by the merged entity. This modification of existing debt obligations is material to investors assessing the registrant's financial position and obligations.
View raw filing on EDGAR →The filing discloses that Talkspace has satisfied all remaining closing conditions for its merger with Universal Health Services, Inc., with closing expected on or around August 17, 2026. The disclosure announces the completion of a material acquisition transaction—specifically, the satisfaction of state healthcare law approvals and the imminent closing of the merger. This represents a completion or near-completion of a material change of control transaction, which is a core M&A activity event.
View raw filing on EDGAR →Banco Santander Chile issued a CHF 100 million bond under its EMTN Programme with a maturity date of August 26, 2031 and yield of 1.2575%. This is a creation of a new direct financial obligation disclosed as a Material Fact to the Chilean Financial Markets Commission (CMF), meeting the definition of debt_issuance.
View raw filing on EDGAR →PetMed Express held its Annual Meeting of Shareholders on August 11, 2026, with shareholders voting on four proposals: election of four directors, advisory approval of named executive officer compensation, ratification of Baker Tilly US, LLP as independent auditor, and approval of an amendment to the 2024 Omnibus Incentive Plan increasing the share reserve by 1,800,000 shares.
View raw filing on EDGAR →This is a clear earnings release disclosing Inovio's financial results for Q2 2026 (quarter ended June 30, 2026), including consolidated balance sheets, statements of operations, and detailed financial metrics (R&D expenses, G&A expenses, net loss per share). The filing explicitly states "INOVIO Reports Second Quarter 2026 Financial Results" and includes quantitative results such as net loss of $6.0 million ($0.07 per share) versus $23.5 million ($0.61 per share) in the prior year period, along with cash position and operational guidance through Q1 2027.
View raw filing on EDGAR →Keith Demmings has been elected to Moody's Board of Directors, effective November 1, 2026. Demmings is the President and CEO of Assurant with nearly three decades of leadership experience and extensive global operating and insurance expertise. His director compensation arrangement includes a $120,000 annual retainer plus a $230,000 RSU award.
View raw filing on EDGAR →The filing discloses a follow-up product order from a recently signed national dealer for three ROSA security units, announced within days of an initial order. This represents a material operational/commercial milestone demonstrating customer momentum and market traction for the company's AI-driven security solutions. While not a formal contract or partnership announcement, the rapid repeat order from a top-10 security services provider signals meaningful business development progress that would affect a reasonable investor's assessment of the company's commercial execution and market acceptance.
View raw filing on EDGAR →The exhibit discloses a private placement of 5,828,342 special warrants closed on July 30, 2026, for aggregate gross proceeds of approximately US$25 million. The special warrants will automatically convert into common shares and common share purchase warrants, creating significant dilution to existing shareholders. This is a classic dilutive equity issuance under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D, and the magnitude (US$25M) and structure (warrant-based conversion) make it material to investors.
View raw filing on EDGAR →The 8-K discloses Dolphin Entertainment's financial results for Q2 2026 and H1 2026 via Item 2.02 (Results of Operations and Financial Condition), with a press release attached as Exhibit 99.1. The filing reports Q2 revenue of $14.4 million (up 2.5% YoY), H1 revenue of $27.2 million (up 3.8% YoY), and a net loss of $1.6 million for Q2 2026. This is a standard quarterly earnings release, material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →John Gerdin was appointed to American Fusion's Board of Directors as an Independent Director and Strategic Advisor, effective August 10–11, 2026. The appointment is structured through a Consulting Services Agreement with JRMS Consulting LLC and brings significant international finance and capital markets expertise to the company's leadership.
View raw filing on EDGAR →Natural Gas Services Group disclosed Q2 2026 financial results (quarter ended June 30, 2026) via an earnings call held on August 11, 2026, with detailed discussion of quarterly performance including rental revenue per horsepower, utilization rates, EBITDA, leverage ratios, and forward guidance.
View raw filing on EDGAR →Ms. Kayla Slick resigned her positions as both an officer and director of Bravo Multinational, Inc. on August 7, 2026. The filing explicitly discloses this departure under Item 5.02 and confirms the resignation was not due to any dispute or disagreement with the Company. This is a clear executive departure event.
View raw filing on EDGAR →APPlife Digital Solutions issued a $170,000 convertible promissory note to an accredited investor under Regulation D. The note is convertible into common stock at a 35% discount to the lowest trading price during the preceding 20 trading days, with conversion rights commencing six months after issuance, resulting in equity dilution upon conversion.
View raw filing on EDGAR →Eagle Point Credit Company, a closed-end investment company, discloses management's unaudited estimate of net asset value (NAV) per common share as of July 31, 2026 ($4.33–$4.43). NAV is a key metric for valuing and assessing the financial position of credit and investment companies, making this disclosure material to investors. The disclosure does not fit a specific financial event category (earnings release, impairment, debt issuance, etc.) but is clearly a financial disclosure relevant to the registrant's valuation and performance.
View raw filing on EDGAR →Realty Income announced the pricing of $875.0 million aggregate principal amount of 3.750% convertible senior notes due 2031 in a Rule 144A private offering, with settlement scheduled for August 14, 2026. This is a material creation of a new direct financial obligation. Although the notes are convertible into common stock, the primary event disclosed is the issuance of debt securities, making debt_issuance the most appropriate classification rather than dilutive_issuance.
View raw filing on EDGAR →The disclosure centers on the Company's conversion from a Delaware corporation to a Delaware Statutory Trust, effective August 24, 2026, which was approved by stockholders on May 20, 2026 and the Board of Directors. This is a material governance and structural change affecting the registrant's legal form and shareholder rights, though it does not fit the specific categories of exec_departure, exec_appointment, exec_compensation, or shareholder_vote_results (the vote already occurred). The conversion is a significant corporate governance event that would affect investor assessment of the registrant's structure and operations.
View raw filing on EDGAR →This exhibit is a press release announcing HUYA Inc.'s unaudited financial results for the second quarter ended June 30, 2026. It discloses quarterly revenues (RMB1,739.3 million, up 11.0% YoY), operating results (narrowed operating loss to RMB7.0 million), and net income (RMB1.6 million vs. prior-year loss of RMB5.5 million), along with segment performance and balance-sheet data. The document explicitly states "HUYA Inc. Reports Second Quarter 2026 Unaudited Financial Results" and includes management commentary on business performance and strategic initiatives. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →Bio-Techne Corporation disclosed fourth quarter and full-year fiscal 2026 financial results on August 12, 2026, reporting quarterly revenue of $321.2 million and annual revenue of $1.2 billion, with GAAP EPS of $0.35 (quarterly) and $1.16 (annual), and adjusted EPS of $0.52 (quarterly) and $1.93 (annual), along with detailed segment performance and non-GAAP reconciliations.
View raw filing on EDGAR →Liquidia Corp issued a press release announcing its financial results for the second quarter ended June 30, 2026, reporting net product sales of $170.4 million, net income of $74.7 million, and adjusted EBITDA of $96.3 million, along with comprehensive operational metrics.
View raw filing on EDGAR →This is a clear earnings release disclosing Protalix's financial results for the second quarter and first half of 2026. The press release (Exhibit 99.1) reports Q2 2026 revenues of $19.8 million, year-to-date revenues of $53.6 million, and year-to-date net income of $22.1 million, along with full-year 2026 revenue guidance of $78.0–$83.0 million. The disclosure includes detailed financial highlights, operational updates on product commercialization (Elfabrio®) and clinical programs (PRX-115), and is accompanied by a conference call. This is a material event affecting investor assessment of the company's financial performance and operational progress.
View raw filing on EDGAR →Humacyte issued a press release on August 12, 2026 disclosing financial results for its fiscal second quarter ended June 30, 2026, including commercial sales of Symvess ($0.4M Q2 2026 vs. $0.1M Q2 2025), net loss ($36.8M Q2 2026 vs. $37.7M Q2 2025), and cash position ($80.3M as of June 30, 2026). The filing explicitly states the press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes detailed financial metrics and operational highlights material to investor assessment.
View raw filing on EDGAR →Cypherpunk Technologies announced Q2 2026 financial results (quarter ended June 30, 2026) with net income of $39.4 million ($0.18 per diluted share), including detailed financial metrics, balance sheet data, and operational highlights. The earnings release was furnished as Exhibit 99.1.
View raw filing on EDGAR →AMCON announced a dual listing of its common stock on the NYSE Texas exchange, effective August 13, 2026, while maintaining its primary listing on NYSE American under the same "DIT" ticker symbol. This is a strategic operational and capital markets event that enhances the company's market presence and accessibility to investors, aligning with management's stated vision of enhancing shareholder value. While not a traditional M&A, governance, or financial event, the dual listing is a material operational milestone that would affect a reasonable investor's assessment of the company's market positioning and liquidity.
View raw filing on EDGAR →Item 2.02 discloses Milestone Pharmaceuticals' second quarter 2026 financial results via a press release furnished as Exhibit 99.1. The filing reports Q2 product revenues of $0.6 million, net loss of $28.6 million ($0.21 per share), cash position of $170.6 million, and operational highlights including CARDAMYST launch progress and Phase 3 trial activation for AFib-RVR. This is a standard earnings release disclosure material to investors assessing the company's financial condition and commercial progress.
View raw filing on EDGAR →UPS entered into an underwriting agreement on August 10, 2026 to issue $1,000,000,000 principal amount of 4.850% Senior Notes due 2031. This is a material creation of a direct financial obligation through debt issuance. While a portion ($450 million) will be contributed to pension trusts, the full $1 billion represents new debt obligations for the company, with net proceeds to be used for general corporate purposes.
View raw filing on EDGAR →Definium announced positive topline results from its Phase 3 Voyage study of DT120 ODT for generalized anxiety disorder, meeting the primary endpoint with statistically significant efficacy (p<0.0001, Cohen's d=0.81). This represents a material clinical development milestone for the company's lead product candidate.
View raw filing on EDGAR →Century Therapeutics issued a press release on August 12, 2026 announcing Q2 2026 financial results for the quarter ended June 30, 2026, disclosing cash position of $197.2 million, R&D expenses of $19.6 million, G&A expenses of $5.8 million, and net loss of $34.6 million, along with material business updates on pipeline programs CNTY-813 (pre-IND meeting completed, IND submission on track for 4Q 2026) and CNTY-308 (clinical trial planned for 2026).
View raw filing on EDGAR →Aprea Therapeutics disclosed Q2 2026 financial results, including an operating loss of $4.0 million, net loss of $3.6 million, and cash position of $41.2 million, along with clinical progress updates on lead programs APR-1051 and ATRN-119.
View raw filing on EDGAR →The Company entered into an underwriting agreement on August 11, 2026, to issue $90 million aggregate principal amount of 9.600% Senior Notes due 2031, with an additional $13.5 million over-allotment option. This is a material creation of a new direct financial obligation through debt issuance, registered under Form S-3 and expected to close on August 14, 2026.
View raw filing on EDGAR →This exhibit is a press release announcing WeRide's unaudited consolidated quarterly and first half financial results for the period ended June 30, 2026. The document discloses detailed financial metrics including total revenue (RMB231.7 million in Q2, up 82.2% YoY), gross margin (37.5%), operating expenses, net loss, EBITDA, and balance sheet information. The filing explicitly states it is issued "pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited" and constitutes "material inside information." This is a classic earnings release event disclosing quarterly and interim financial results.
View raw filing on EDGAR →Cencora discloses that beginning July 1, 2026, certain Walgreens volume outside the prime vendor agreement "began moving outside the Company," while reaffirming its adjusted diluted EPS guidance. This is a material operational event involving loss of customer volume from a major customer (Walgreens), though the company characterizes it as "fully contemplated" and notes the prime vendor agreement remains unchanged. The disclosure is operational in nature (customer volume shift) rather than fitting a specific category like M&A, impairment, or covenant breach.
View raw filing on EDGAR →The filing discloses entry into multiple material definitive agreements in connection with the issuance and sale of Class A-1 through Class A-4 Asset Backed Notes by Honda Auto Receivables 2026-3 Owner Trust on August 12, 2026. The core transaction involves creation of a new direct financial obligation through securitization of auto receivables, with AHFC retaining at least 5% of each note class. This is a debt issuance structured as an asset-backed securitization, a material capital-raising event.
View raw filing on EDGAR →The filing discloses completion of a disposition of 21 single-family residential units from the Ballast portfolio for approximately $7.1 million in aggregate sales price and $6.4 million in net proceeds. This is a material asset disposition under Item 2.01, representing a significant reduction in the Company's real estate holdings and generating material cash proceeds.
View raw filing on EDGAR →The filing discloses Capstone Energy+'s financial results for the first quarter of fiscal 2027 ended June 30, 2026, via a press release furnished as Exhibit 99.1. The disclosure includes revenue of $24.9 million, gross profit of $8.8 million (up 16% year-over-year), operating income of $1.0 million, and net income of $0.04 million, along with detailed operational highlights and management commentary. This is a standard quarterly earnings release material to investors assessing the company's financial performance.
View raw filing on EDGAR →Outlook Therapeutics disclosed substantial doubt about its ability to continue as a going concern, citing a critical cash position of $11.2 million as of June 30, 2026 (and $7.7 million as of March 31, 2026) that is estimated to fund operations only into September 2026, along with substantial debt obligations.
View raw filing on EDGAR →Hyperion DeFi, Inc. issued a press release announcing its financial results for the fiscal quarter ended June 30, 2026, reporting record net income of $31.0M and adjusted EBITDA of $53.7M, along with detailed quarterly financial metrics and guidance. The company will host a conference call to discuss its financial and operating results, with an investor presentation furnished as a supplemental exhibit.
View raw filing on EDGAR →